Crossmark

Integrated theranostic nanoplatform empowers precision cancer care via radionuclide-labeled NIR-II aggregation-induced emission luminogens

Crossref DOI link: https://doi.org/10.1038/s41467-026-74359-4

Published Online: 2026-06-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Guo-Ling

Hou, Da-Yong https://orcid.org/0000-0002-7567-8663
Chen, Yixuan

Chen, Pu

Wu, Jiong-Cheng

Wang, Yue-Ze https://orcid.org/0009-0007-5029-806X
Xu, Wanhai https://orcid.org/0000-0003-3442-7988
Zhao, Zheng https://orcid.org/0000-0002-5536-0439
Tang, Ben Zhong https://orcid.org/0000-0002-0293-964X
Feng, Hai-Tao https://orcid.org/0000-0003-2388-0955
License Information

Text and Data Mining valid from 2026-06-12

Accepted Manuscript valid from 2026-06-12
More Information

Article History

Received: 24 April 2025

Accepted: 4 June 2026

First Online: 12 June 2026

Competing interests

: The authors declare no competing interests.